Pub. Date : 2012 Jan
PMID : 22310593
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The main aim of this study was to evaluate the effect of conversion from twice-daily tacrolimus (tacrolimus-BID) to once-daily tacrolimus (tacrolimus-OD) on glucose intolerance in stable kidney transplant patients. | Tacrolimus | BH3 interacting domain death agonist | Homo sapiens |
| 2 | The main aim of this study was to evaluate the effect of conversion from twice-daily tacrolimus (tacrolimus-BID) to once-daily tacrolimus (tacrolimus-OD) on glucose intolerance in stable kidney transplant patients. | Tacrolimus | BH3 interacting domain death agonist | Homo sapiens |
| 3 | The main aim of this study was to evaluate the effect of conversion from twice-daily tacrolimus (tacrolimus-BID) to once-daily tacrolimus (tacrolimus-OD) on glucose intolerance in stable kidney transplant patients. | Tacrolimus | BH3 interacting domain death agonist | Homo sapiens |
| 4 | The main aim of this study was to evaluate the effect of conversion from twice-daily tacrolimus (tacrolimus-BID) to once-daily tacrolimus (tacrolimus-OD) on glucose intolerance in stable kidney transplant patients. | Tacrolimus | BH3 interacting domain death agonist | Homo sapiens |
| 5 | CONCLUSION: The results of this study suggests that conversion from tacrolimus-BID to tacrolimus-OD may benefit kidney transplant patients with glucose intolerance because of improved insulin secretion. | Tacrolimus | BH3 interacting domain death agonist | Homo sapiens |